Last reviewed · How we verify
NCT05975112
The Incidence of Hyperfibrinolysis During Vaginal Delivery and Cesarean Section
trial testing Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge in Hyperfibrinolysis in 780 participants. Status unknown.
30 November 2024
Quick facts
| Lead sponsor | Medical University of Graz |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 780 |
| Start date | 1 June 2023 |
| Primary completion | 30 November 2024 |
| Estimated completion | 17 April 2025 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge
Conditions studied
- Hyperfibrinolysis — all drugs for Hyperfibrinolysis →
- Cesarean Section Complications — all drugs for Cesarean Section Complications →
- Coagulation Defect; Bleeding — all drugs for Coagulation Defect; Bleeding →
- Peripartum Haemorrhage — all drugs for Peripartum Haemorrhage →
Sponsor
Medical University of Graz
Who can join
18 and older, female only, with Hyperfibrinolysis or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to find out if there are common major changes in coagulation immediately after delivery of the newborn during Cesarean (C) -section and vaginal birth.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Non-Invasive Measurement of Serum Haemoglobin for the Detection of Postpartum Anaemia: A Prospective Observational Study.
Honnef G, Hallmann B, Eichlseder M, Eichinger M, et al · · 2026 · PMID 41976784 · DOI 10.3390/jcm15072483 -
Hyperfibrinolysis During Caesarean Section and Vaginal Delivery: A Prospective Cross-Sectional Study in the Delivery Room.
Zoidl P, Honnef G, Eichinger M, Eichlseder M, et al · · 2025 · PMID 41517278 · DOI 10.3390/jcm15010027
Verify or expand the search:
- PubMed search for NCT05975112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Medical University of Graz trials
Trials by the same sponsor.
- NCT07498244 — Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients · recruiting
- NCT07492823 — Clinical Applicability of Liquid Biopsy in Chondrosarcoma · not yet recruiting
- NCT07297615 — 3D Liver Volumetry · NA · not yet recruiting
- NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
- NCT07376096 — Liquid Biopsy in Germ Cell Tumors · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05975112 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Graz
- Last refreshed: 21 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05975112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing